- Home
- DTCK vs BOLT Comparison
DTCK vs BOLT Comparison
Compare DTCK & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- BOLT
- Stock Information
- Founded
- DTCK 1999
- BOLT 2015
- Country
- DTCK Singapore
- BOLT United States
- Employees
- DTCK N/A
- BOLT N/A
- Industry
- DTCK Farming/Seeds/Milling
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- BOLT Health Care
- Exchange
- DTCK Nasdaq
- BOLT Nasdaq
- Market Cap
- DTCK 19.3M
- BOLT 16.8M
- IPO Year
- DTCK 2023
- BOLT 2021
- Fundamental
- Price
- DTCK $0.79
- BOLT $6.09
- Analyst Decision
- DTCK
- BOLT Buy
- Analyst Count
- DTCK 0
- BOLT 3
- Target Price
- DTCK N/A
- BOLT $50.00
- AVG Volume (30 Days)
- DTCK 3.6M
- BOLT 24.1K
- Earning Date
- DTCK 04-30-2025
- BOLT 08-12-2025
- Dividend Yield
- DTCK N/A
- BOLT N/A
- EPS Growth
- DTCK N/A
- BOLT N/A
- EPS
- DTCK N/A
- BOLT N/A
- Revenue
- DTCK $132,369,000.00
- BOLT $3,638,000.00
- Revenue This Year
- DTCK N/A
- BOLT N/A
- Revenue Next Year
- DTCK N/A
- BOLT $24.14
- P/E Ratio
- DTCK N/A
- BOLT N/A
- Revenue Growth
- DTCK N/A
- BOLT N/A
- 52 Week Low
- DTCK $0.40
- BOLT $5.20
- 52 Week High
- DTCK $1.50
- BOLT $15.60
- Technical
- Relative Strength Index (RSI)
- DTCK 54.13
- BOLT 42.99
- Support Level
- DTCK $0.78
- BOLT $5.52
- Resistance Level
- DTCK $0.93
- BOLT $6.07
- Average True Range (ATR)
- DTCK 0.19
- BOLT 0.30
- MACD
- DTCK -0.01
- BOLT 0.01
- Stochastic Oscillator
- DTCK 19.54
- BOLT 25.55
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.